SIRT1 genetic variation and mortality in type 2 diabetes: interaction with smoking and dietary niacin
- 1 March 2009
- journal article
- research article
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 46 (6) , 836-841
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Vasoprotective effects of resveratrol and SIRT1: attenuation of cigarette smoke-induced oxidative stress and proinflammatory phenotypic alterationsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- SIRT1, an Antiinflammatory and Antiaging Protein, Is Decreased in Lungs of Patients with Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetesNature, 2007
- The Rotterdam Study: objectives and design updateEuropean Journal of Epidemiology, 2007
- Resveratrol improves health and survival of mice on a high-calorie dietNature, 2006
- Control of AIF-mediated Cell Death by the Functional Interplay of SIRT1 and PARP-1 in Response to DNA DamageCell Cycle, 2006
- Sirt1 Regulates Insulin Secretion by Repressing UCP2 in Pancreatic β CellsPLOS Biology, 2005
- Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-γNature, 2004
- Stress-Dependent Regulation of FOXO Transcription Factors by the SIRT1 DeacetylaseScience, 2004
- Phylogenetic Classification of Prokaryotic and Eukaryotic Sir2-like ProteinsBiochemical and Biophysical Research Communications, 2000